se Of Parpatadyarishta in the management of Prostate growth related urinary incontinence

Phase 2

Completed

• Conditions: Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

• Registration Number: CTRI/2019/05/019230
• Lead Sponsor: CSMSS AYURVED MAHAVIDYALAYA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-12-30
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 94

Inclusion Criteria

1.Patients of age between 40 years to 70 years who are diagnosed case of benign Prostatic Hyperplasia.

2.Patients having International Prostate Symptom Score (IPSS) [9] of mild to moderate score (IPSS <19).

3.Patients having post voiding residue of more than 200 ml.[9]

4.Patient Having PSA lower than 4.0 ng/mL[9]

5.Prostate Weight less than 60 gm.

6.Patients and/or his signatory guardian/responsible person had understood the Consent in his own language and willing to follow the suggestion through the assessment period. (i.e. follow up intervals, medicine dose and suggested investigation and examination

Exclusion Criteria

1.Diagnosed case of bladder & prostate cancer.

2.Any prior surgery which could induce dysuria.

3.Patients having urinary flow less than 5ml/sec.

4.Patient having acute urinary tract infection

5.Urethral Stricture.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
relief in Bladder outlet Obstruction by relief in <br/ ><br>1.Incomplete emptying of Bladder <br/ ><br>2.Increased Frequency of Urine <br/ ><br>3.Intermittency in urination <br/ ><br>4.Urgency in micturition <br/ ><br>5.Weak Stream of urine <br/ ><br>6.Straining during Urinaton <br/ ><br>7.Nocturia <br/ ><br>Timepoint: 1.International Prostate Symptom Score (IPSS) on Day one, 15TH DAY, 30TH DAY, 45TH DAY, 60TH DAY <br/ ><br>2.International Prostate Symptom Score Quality Of Life Index I.P.S.S. QOL on Day one, 15TH DAY, 30TH DAY, 45TH DAY, 60TH DAY <br/ ><br>3.Digital Rectal Examination DRE on Day one, 15TH DAY, 30TH DAY, 45TH DAY, 60TH DAY <br/ ><br>4.Urine Flow (Uroflowmetry) Day one and 60TH DAY <br/ ><br>5.Post Void Residual Urine Volume Ultrasnography on Day one and 60TH DAY

Secondary Outcome Measures

Name	Time	Method
Parpatadyarishta by reducing Prostate Size or retarding further growthTimepoint: Prostate Size By Ultrasnography on Day one and 60TH DAY of treatment